Ken Shirato Selected Research

Ken Shirato Research Topics

Disease

4	Body Weight (Weight, Body) 01/2013 - 01/2011
3	Inflammation (Inflammations) 01/2017 - 02/2009
3	Hypertrophy 12/2011 - 04/2009
3	Neoplasms (Cancer) 01/2011 - 01/2007
3	Necrosis 02/2007 - 04/2006
2	Bacterial Infections (Bacterial Infection) 01/2022 - 11/2009
2	Hypoxia (Hypoxemia) 01/2011 - 11/2009
2	Atrophy 01/2011 - 04/2009
2	Multiple Myeloma 03/2009 - 01/2008
1	COVID-19 02/2021
1	Obesity 01/2017
1	Infections 01/2017
1	Insulin Resistance 01/2017
1	Chronic Disease (Chronic Diseases) 01/2015
1	Rheumatoid Arthritis 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 09/2013
1	Insulinoma 09/2013
1	Lymphopenia (Lymphocytopenia) 01/2013
1	Agranulocytosis (Granulocytopenia) 01/2013
1	Emphysema 05/2012
1	Muscular Atrophy (Muscle Atrophy) 12/2011
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Retinoblastoma (Glioblastoma, Retinal) 01/2008
1	Asthma (Bronchial Asthma) 06/2007
1	Stomach Neoplasms (Stomach Cancer) 02/2007
1	Neuroblastoma 02/2007
1	Glioblastoma (Glioblastoma Multiforme) 01/2007
1	Melanoma (Melanoma, Malignant) 11/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2006

Drug/Important Bio-Agent (IBA)

7	3-aminophenoxazoneIBA 03/2009 - 04/2006
6	phenoxazineIBA 01/2008 - 04/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 04/2006
3	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2009
3	2- amino- 4,4alpha- dihydro- 4alpha,7- dimethyl- 3H- phenoxazine- 3- oneIBA 01/2008 - 04/2006
3	CaspasesIBA 02/2007 - 01/2007
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017 - 02/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2013
2	AdipokinesIBA 01/2017 - 02/2009
2	Polysaccharides (Glycans)IBA 09/2013 - 01/2011
2	ClenbuterolIBA 01/2013 - 06/2007
2	Polymethyl Methacrylate (Sol)IBA 12/2011 - 08/2011
2	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2011 - 01/2011
2	ZincIBA 01/2011 - 04/2009
2	Caspase 3 (Caspase-3)IBA 01/2008 - 02/2007
2	Annexin A5IBA 01/2007 - 04/2006
1	SARS-CoV-2 spike proteinIBA 02/2021
1	AcidsIBA 09/2013
1	Sialic AcidsIBA 09/2013
1	Cytidine Monophosphate (CMP)IBA 09/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2013
1	Vitamin B Complex (B Vitamins)IBA 01/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2012
1	SmokeIBA 05/2012
1	Matrix Metalloproteinases (MMPs)IBA 05/2012
1	Muscle Proteins (Muscle Protein)IBA 12/2011
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 08/2011
1	GlucocorticoidsIBA 08/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2011
1	Ethanol (Ethyl Alcohol)IBA 06/2011
1	Hemoglobins (Hemoglobin)IBA 06/2011
1	EnzymesIBA 01/2011
1	AcetylglucosamineIBA 01/2011
1	NucleotidesIBA 01/2011
1	GlycosyltransferasesIBA 01/2011
1	SugarsIBA 01/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	Hormones (Hormone)IBA 01/2011
1	Messenger RNA (mRNA)IBA 11/2009
1	cobaltous chloride (cobalt(II)chloride)IBA 11/2009
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2009
1	JNK Mitogen-Activated Protein KinasesIBA 03/2009
1	Antineoplastic Agents (Antineoplastics)IBA 01/2008
1	Hematoxylin (Haematoxylon)IBA 01/2008
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2008
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 02/2007
1	CreatinineIBA 11/2006
1	Alanine Transaminase (SGPT)IBA 11/2006
1	Dactinomycin (Actinomycin)FDA LinkGeneric 11/2006
1	Urea (Carbamide)FDA LinkGeneric 11/2006
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2006
1	NitrogenIBA 11/2006
1	CytokinesIBA 04/2006
1	LigandsIBA 04/2006
1	Propidium (Propidium Iodide)IBA 04/2006
1	PhosphatidylserinesIBA 04/2006

Therapy/Procedure

1	Phage Therapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2008
1	Therapeutics 06/2007